Conform Trial: Major Milestone Achieved

We are thrilled to celebrate a major milestone in clinical research! On August 8, 2025, our team successfully completed the very first implant day for the Conform Clinical Trial, enrolling and treating our first three patients with the Conformal CLAAS System for Left Atrial Appendage Occlusion.

This remarkable achievement was made possible through the dedication, collaboration, and unwavering commitment of Dr. Giancarlo Speziani, Anne Dallas, Cynthia Paysor, and Gerardo Bustos. Their expertise and teamwork has set the stage for continued excellence in advancing cardiovascular innovation.

The Conform Trial is designed to evaluate the safety and effectiveness of the Conformal CLAAS System, an important step toward expanding treatment options for patients with atrial fibrillation.

Congratulations to the entire team on this inspiring accomplishment!

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

Understanding Hypoglycemia and the CLEAR Study

The CLEAR Study is a groundbreaking, international research effort funded by the NIH that aims to help people with Type 1 diabetes (T1D) who can no longer sense when their blood sugar is dangerously...

News

Did you know? Women, Hormones, and Heart Risk

Heart disease is often thought of as a “man’s disease,” but it remains the leading cause of death for women in the United States. We asked Katie Love, MD, MSc, an investigator at the AdventHealth...

News

Meet the Team: Dr. Katie Love, MD

Meet Dr. Katie Love an Endocrinologist and Associate Investigator at the AdventHealth Translational Research Institute. Dr. Love was diagnosed with Type 1 diabetes at just four years old and decided...